As pharmaceutical suppliers, we have developed a focused range of niche, small molecule APIs to meet the growing demands of the industry. By concentrating on specialized molecules, we provide reliable solutions that strengthen our partners’ competitiveness and address evolving therapeutic needs.
We actively invest in research and innovation to bring new APIs to market, ensuring our customers benefit from timely, high quality products. This commitment allows us to support their development pipelines and contribute meaningfully to the progress of global healthcare.
| Apixaban |
| Atomoxetine HCl |
| Edoxaban tosylate |
| Escitalopram oxalate |
| Ivacaftor |
| Rivaroxaban |
| Trospium Chloride |
| Xanomeline Tartrate |
| Dabigatran Etexilate | Mirabegron |
| Deferasirox | Montelukast Sodium |
| Desvenlafaxine Succinate | Olmesartan Medoxomil |
| Donepezil HCl | Oseltamivir phosphate |
| Efinaconazole | Resmetirom |
| Levocetirizine Di HCl | Tenofavir alafenamide fumarate |
| Levothyroxine Sodium | Vildagliptin |
| Lurasidone HCl | Ziprasidone hydrochloride |
| Asenapine | Orforglipron |
| Apremilast | Ranolazine |
| Atogepant | Rimegepant |
| Bempedoic Acid | Tezacaftor |
| Deferiprone | Ticagrelor |
| Elexacaftor | Tofacitinib Citrate |
| Fluvoxamine Maleate | Tolvaptan |
| Fingolimod HCl | Torsamide |
| Linagliptin | Vibegron |
| Mirtazapine |
